Congratulations to Pharmacology Asst. Professor/Research April Risinger, Ph.D., for being awarded a Voelcker Fund Pilot Grant!!!

April Risinger, Ph.D.

Assistant Profeesor/Research April Risinger, Ph.D., was awarded $100,000, by the Trustees of the Max and Minnie Tomerlin Voelcker Fund, for her pilot study titled: 'Identifying mechanisms by which microtubule stabilizing drugs disrupt oncogenic signaling pathways'.

The Voelcker Fund is dedicated to advancing medical research in key areas, including cancer and heart disease. The UT Health awardees are studying various aspects of these diseases. The cancer-related projects focus on the most difficult-to-treat brain, breast and colorectal tumors and innovative new immunologic cancer therapies. Another project seeks to improve heart function damaged by aging.

“UT Health San Antonio researchers are studying cancer and other diseases for which there are few answers,” said Banks Smith, Voelcker Fund trustee. “We want to see these quality research programs flourish and provide the answers society needs.”

“The Voelcker Fund medical advisory committee continues to have high praise for the quality of our researchers’ applications,” said Andrea Giuffrida, Ph.D., vice president for research at UT Health San Antonio. “This is a credit to our faculty and the scientific excellence of their programs.”

Over the history of the Voelcker Fund, the trustees have supported more than 30 scientists at UT Health San Antonio. “The trustees’ investments play a major role in helping these young future leaders in medical research to launch their scientific careers,” President Henrich said.

April conducts research in the lab of Susan Mooberry, Ph.D., Pharmacology Professor.

Congratulations Dr. Risinger!